[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CN114450286A - Material of organic electroluminescent device - Google Patents

Material of organic electroluminescent device Download PDF

Info

Publication number
CN114450286A
CN114450286A CN202080064440.7A CN202080064440A CN114450286A CN 114450286 A CN114450286 A CN 114450286A CN 202080064440 A CN202080064440 A CN 202080064440A CN 114450286 A CN114450286 A CN 114450286A
Authority
CN
China
Prior art keywords
groups
substituted
atoms
radical
integer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202080064440.7A
Other languages
Chinese (zh)
Inventor
阿米尔·帕勒姆
乔纳斯·克罗巴
延斯·恩格哈特
安雅·雅提斯奇
克里斯蒂安·艾克霍夫
克里斯蒂安·埃伦赖希
詹斯·凯泽
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CN114450286A publication Critical patent/CN114450286A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/14Carrier transporting layers
    • H10K50/15Hole transporting layers
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/615Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6574Polycyclic condensed heteroaromatic hydrocarbons comprising only oxygen in the heteroaromatic polycondensed ring system, e.g. cumarine dyes
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6576Polycyclic condensed heteroaromatic hydrocarbons comprising only sulfur in the heteroaromatic polycondensed ring system, e.g. benzothiophene
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1044Heterocyclic compounds characterised by ligands containing two nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1088Heterocyclic compounds characterised by ligands containing oxygen as the only heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1092Heterocyclic compounds characterised by ligands containing sulfur as the only heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00Properties of the organic materials covered by group H10K85/00
    • H10K2101/10Triplet emission
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K2101/00Properties of the organic materials covered by group H10K85/00
    • H10K2101/90Multiple hosts in the emissive layer
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]
    • H10K50/11OLEDs or polymer light-emitting diodes [PLED] characterised by the electroluminescent [EL] layers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02EREDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E10/00Energy generation through renewable energy sources
    • Y02E10/50Photovoltaic [PV] energy
    • Y02E10/549Organic PV cells

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Optics & Photonics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)

Abstract

The present invention relates to compounds of formula (1), the use of the compounds in electronic devices, and electronic devices comprising compounds of formula (1). The invention also relates to a method for producing the compounds of formula (1) and to agents containing one or more compounds of formula (1).

Description

Material of organic electroluminescent device
The present invention relates to compounds of formula (1), the use of said compounds in electronic devices and electronic devices comprising compounds of formula (1). The invention also relates to a method for producing the compounds of formula (1) and to agents containing one or more compounds of formula (1).
The structure of organic electroluminescent devices (OLEDs) is described, for example, in US 4539507, wherein the organic semiconductor is used as a functional material. The light-emitting material used here is often an organometallic complex that exhibits phosphorescence. For quantum mechanical reasons, the efficiency can be increased up to four-fold using phosphorescent rather than fluorescent emitters. However, in general, there is still a need for improvement in the case of OLEDs, in particular also in the case of OLEDs which exhibit triplet emission (phosphorescence), for example in terms of efficiency, operating voltage and lifetime.
The properties of phosphorescent OLEDs are determined not only by the triplet emitters but also by other materials used together with the triplet emitters in the OLED, for example matrix materials, also referred to as host materials. Thus, improving these materials and their charge transport properties can also lead to significant improvements in OLED properties.
Thus, the choice of the matrix material in the light-emitting layer comprising phosphorescent emitters has a great influence on the properties of the OLED, in particular in terms of efficiency. The host material limits quenching of the excited state emitter molecules by energy transfer.
It is an object of the present invention to provide compounds suitable for use in OLEDs. More specifically, it was an object of the present invention to provide compounds which are particularly suitable as matrix materials for phosphorescent emitters in OLEDs and, depending on the specific structures and groups present in the compounds, also as Hole Transport Materials (HTM), Electron Blocking Materials (EBM), Electron Transport Materials (ETM), Hole Blocking Materials (HBM). It is another object of the present invention to provide other organic semiconductors for use in organic electroluminescent devices to provide those skilled in the art with more possible choices of materials for fabricating OLEDs.
Compounds comprising lactam derivatives and their use as OLED materials, more particularly as matrix materials for phosphorescent emitters, are known from the prior art (for example from WO 2013/064206).
It has now been unexpectedly found that specific compounds comprising a lactam moiety in combination with a naphthalene moiety, as described in more detail below, exhibit excellent properties when used in OLEDs, in particular when used as matrix materials for red phosphorescent emitters. In fact, these compounds lead to OLEDs which exhibit better properties with respect to lifetime and/or efficiency and/or electroluminescence. In addition, these compounds have a high glass transition temperature and good thermal stability, which are important properties for OLED materials, especially when the materials are vapor deposited by vacuum methods.
The invention therefore relates to these compounds and to electronic devices, in particular organic electroluminescent devices, comprising compounds of this type. The invention also relates to mixtures and formulations comprising the mixtures.
The invention relates to compounds of formula (1),
Figure BDA0003545241200000031
where the following applies to the symbols and labels used:
ArSon each occurrence, identically or differently, represents a single bond or an aromatic or heteroaromatic ring system having from 5 to 30 aromatic ring atoms, which may be substituted by one or more R groups;
X1to X4At each occurrence, the same or different surfaceShow CR1Or N;
Y1to Y4At each occurrence, identically or differently representing CR2Or N; provided that Ar shown in formula (1)SRadical and one Y representing C1、Y2、Y3Or Y4Bonding of groups; and exactly two non-adjacent Y groups, i.e. Y1And Y4、Y1And Y3Or Y2And Y4Represents N;
the method is characterized in that:
Z1to Z8At each occurrence, identically or differently representing CR3Or N; wherein is selected from Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7And Z7-Z8At least two adjacent Z groups together form a heteroaromatic ring system selected from the group consisting of the formulae (Het-1) or (Het-2),
Figure BDA0003545241200000041
wherein, in (Het-1) and (Het-2), the symbols*Indication and Z in formula (1)1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7Or Z7-Z8The bonding position of (a);
Z9to Z12At each occurrence, identically or differently representing CR3Or N;
RNon each occurrence, the same or different indicates: h, D, F, Cl, Br, I, CN, Si (R)3Straight-chain alkyl, alkoxy or thioalkyl groups having 1 to 40C atoms or branched or cyclic alkyl, alkoxy or thioalkyl groups having 3 to 40C atoms, which may each be substituted by one or more R groups, where in each case one or more non-adjacent CH groups2The radical may be substituted by RC ═ CR, C ≡ C, Si (R)2、Ge(R)2、Sn(R)2、C=O、C=S、C=Se、P(=O)(R)、SO、SO2O, S or CONR, and wherein one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, an aromatic or heteroaromatic ring system having from 5 to 60 aromatic ring atoms, which can be substituted in each case by one or more R groups, or an aryloxy group having from 5 to 60 aromatic ring atoms, which can be substituted by one or more R groups;
and is selected from Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7、Z7-Z8、Z9-Z10、Z10-Z11And Z11-Z12Together at least two adjacent Z groups form an aromatic ring of formula (Aro-1),
Figure BDA0003545241200000042
wherein Z13To Z16At each occurrence, identically or differently representing CR3Or N; and wherein the symbols*Indication with Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7、Z7-Z8、Z9-Z10、Z10-Z11Or Z11-Z12The bonding position of (a);
R1、R2and R3On each occurrence, the same or different indicates: h, D, F, Cl, Br, I, CHO, CN, C (═ O) Ar, P (═ O) (Ar)2,S(=O)Ar,S(=O)2Ar,N(R)2,N(Ar)2,NO2,Si(R)3,B(OR)2,OSO2R, a linear alkyl, alkoxy or thioalkyl radical having 1 to 40C atoms or a branched or cyclic alkyl, alkoxy or thioalkyl radical having 3 to 40C atomsThe thioalkyl groups can each be substituted by one or more R groups, where in each case one or more non-adjacent CH groups2The radicals may be substituted by RC ═ CR, C ≡ C, Si (R)2、Ge(R)2、Sn(R)2、C=O、C=S、C=Se、P(=O)(R)、SO、SO2O, S or CONR, and wherein one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, an aromatic or heteroaromatic ring system having from 5 to 60 aromatic ring atoms, which can be substituted in each case by one or more R groups, or an aryloxy group having from 5 to 60 aromatic ring atoms, which can be substituted by one or more R groups; wherein two adjacent R1The radicals may together form an aliphatic or aromatic ring system which may be substituted by one or more R groups, where one R group2Group and one R1The radicals may form a ring which may be substituted by one or more R groups, and wherein two adjacent R groups3The groups may together form an aliphatic or aromatic ring system, which may be substituted by one or more R groups;
r, on each occurrence, represents, identically or differently: h, D, F, Cl, Br, I, CHO, CN, C (═ O) Ar, P (═ O) (Ar)2,S(=O)Ar,S(=O)2Ar,N(R′)2,N(Ar)2,NO2,Si(R′)3,B(OR′)2,OSO2R 'is a linear alkyl, alkoxy or thioalkyl radical having 1 to 40C atoms or a branched or cyclic alkyl, alkoxy or thioalkyl radical having 3 to 40C atoms, which may each be substituted by one or more R' radicals, where in each case one or more non-adjacent CH radicals2The radicals may be substituted by R ' C ═ CR ', C ≡ C, Si (R ')2、Ge(R′)2、Sn(R′)2、C=O、C=S、C=Se、P(=O)(R′)、SO、SO2O, S or CONR' and in which one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, aromatic or heteroaromatic ring systems having from 5 to 60 aromatic ring atoms, said aromatic or heteroaromatic ring systemsThe heteroaromatic ring systems may be substituted in each case by one or more R 'groups, or aryloxy groups having from 5 to 60 aromatic ring atoms, which may be substituted by one or more R' groups; wherein two adjacent R groups may together form an aliphatic or aromatic ring system, which may be substituted by one or more R' groups;
ar is, identically or differently on each occurrence, an aromatic or heteroaromatic ring system having from 5 to 60 aromatic ring atoms, which may also be substituted in each case by one or more R' groups;
r', at each occurrence, represents, identically or differently: h, D, F, Cl, Br, I, CN, a linear alkyl, alkoxy or thioalkyl radical having 1 to 20C atoms or a branched or cyclic alkyl, alkoxy or thioalkyl radical having 3 to 20C atoms, where in each case one or more non-adjacent CH' s2The radicals being selected from SO, SO2O, S and in which one or more H atoms may be replaced by D, F, Cl, Br or I, or an aromatic or heteroaromatic ring system having from 5 to 24 aromatic ring atoms.
Furthermore, the following definitions of chemical groups apply for the purposes of the present application:
adjacent groups in the sense of the present invention are groups which are bonded to atoms which are directly connected to one another or to the same atom.
An aryl group in the sense of the present invention contains 6 to 60 aromatic ring atoms; heteroaryl groups in the sense of the present invention contain 5 to 60 aromatic ring atoms, at least one of which is a heteroatom. The heteroatom is preferably selected from N, O and S. This represents a basic definition. If other preferences are indicated in the description of the invention, for example with respect to the number of aromatic ring atoms or heteroatoms present, these preferences apply.
An aryl group or heteroaryl group is here understood to mean a simple aromatic ring, i.e. benzene, or a simple heteroaromatic ring, for example pyridine, pyrimidine or thiophene, or a condensed (fused) aromatic or heteroaromatic polycyclic ring, for example naphthalene, phenanthrene, quinoline or carbazole. A condensed (fused) aromatic or heteroaromatic polycyclic ring in the sense of this application consists of two or more simple aromatic or heteroaromatic rings condensed with one another.
Aromatic or heteroaromatic radicals which may be substituted in each case by the abovementioned radicals and may be attached to the aromatic or heteroaromatic ring system via any desired position are to be understood as meaning in particular radicals derived from: benzene, naphthalene, anthracene, phenanthrene, pyrene, dihydropyrene, chicory, perylene, fluoranthene, benzanthracene, tetracene, pentacene, benzopyrene, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5, 6-quinoline, benzo-6, 7-quinoline, benzo-7, 8-quinoline, phenothiazine, thiophene
Figure BDA0003545241200000071
Oxazines, pyrazoles, indazoles, imidazoles, benzimidazoles, naphthoimidazoles, phenanthroimidazoles, pyridoimidazoles, pyrazinoimidazoles, quinoxaloimidazoles,
Figure BDA0003545241200000072
Azole, benzo
Figure BDA0003545241200000073
Azoles, naphtho
Figure BDA0003545241200000074
Azole, anthracenes
Figure BDA0003545241200000075
Azole, phenanthro
Figure BDA0003545241200000076
Oxazole, iso
Figure BDA0003545241200000077
Oxazole, 1, 2-thiazole, 1, 3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, quinoxaline, pyrazine, phenazine, naphthyridine, azacarbazole, benzocarbazine, phenanthroline, 1,2, 3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3-
Figure BDA0003545241200000078
Diazole, 1,2,4-
Figure BDA0003545241200000079
Oxadiazole, 1,2,5-
Figure BDA00035452412000000710
Oxadiazole, 1,3,4-
Figure BDA00035452412000000711
Oxadiazoles, 1,2, 3-thiadiazoles, 1,2, 4-thiadiazoles, 1,2, 5-thiadiazoles, 1,3, 4-thiadiazoles, 1,3, 5-triazines, 1,2, 4-triazines, 1,2, 3-triazines, tetrazoles, 1,2,4, 5-tetrazines, 1,2,3, 4-tetrazines, 1,2,3, 5-tetrazines, purines, pteridines, indolizines and benzothiadiazoles.
An aryloxy group according to the definition of the present invention is taken to mean an aryl group as defined above bonded via an oxygen atom. Similar definitions apply to heteroaryloxy groups.
An aromatic ring system in the sense of the present invention contains 6 to 60C atoms in the ring system. Heteroaromatic ring systems in the sense of the present invention contain 5 to 60 aromatic ring atoms, at least one of which is a heteroatom. The heteroatom is preferably selected from N, O and/or S. An aromatic or heteroaromatic ring system in the sense of the present invention is intended to be taken to mean a system which does not necessarily contain only aryl or heteroaryl groups, but in which a plurality of aryl or heteroaryl groups may also be linked by non-aromatic units (preferably less than 10% of atoms other than H), for example sp3-hybridized C, Si, N or O atoms, sp2-a hybridized C or N atom, or an sp-hybridized C atom. Thus, for example, systems such as 9,9 '-spirobifluorenes, 9' -diarylfluorenes, triarylamines, diaryl ethers, stilbenes, etc., are also intended to be considered aromatic ring systems in the sense of the present invention, and also systems in which two or more aryl groups are connected, for example, by a linear or cyclic alkyl, alkenyl or alkynyl group or by a silyl group. Furthermore, wherein two or more aryl or heteroaryl groups are linked to each other via a single bondLinked systems, for example, such as biphenyl, terphenyl or diphenyltriazine, are also to be regarded as aromatic or heteroaromatic ring systems in the sense of the present invention.
Aromatic or heteroaromatic ring systems having from 5 to 60 aromatic ring atoms, which may also be substituted in each case by a radical as defined above and may be attached to the aromatic or heteroaromatic radical via any desired position, are to be understood as meaning in particular radicals derived from: benzene, naphthalene, anthracene, benzanthracene, phenanthrene, triphenylene, pyrene, chicory, perylene, fluoranthene, tetracene, pentacene, benzopyrene, biphenyl, terphenyl subunit, quaterphenyl, fluorene, spirobifluorene, dihydrophenanthrene, dihydropyrene, tetrahydropyrene, cis-or trans-indenofluorene, triindene, isotridecyl, spiroisotridecyl, furan, benzofuran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobenzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, indolocarbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzo-5, 6-quinoline, benzo-6, 7-quinoline, benzo-7, 8-quinoline, phenothiazine, thiophene
Figure BDA0003545241200000081
Oxazines, pyrazoles, indazoles, imidazoles, benzimidazoles, naphthoimidazoles, phenanthroimidazoles, pyridoimidazoles, pyrazinoimidazoles, quinoxaloimidazoles,
Figure BDA0003545241200000082
Azole, benzo
Figure BDA0003545241200000083
Azoles, naphtho
Figure BDA0003545241200000084
Azoles, anthracenes
Figure BDA0003545241200000085
Azole, phenanthro
Figure BDA0003545241200000086
Oxazole, iso
Figure BDA0003545241200000087
Oxazole, 1, 2-thiazole, 1, 3-thiazole, benzothiazole, pyridazine, benzopyridazine, pyrimidine, benzopyrimidine, quinoxaline, 1, 5-diaza anthracene, 2, 7-diaza pyrene, 2, 3-diaza pyrene, 1, 6-diaza pyrene, 1, 8-diaza pyrene, 4,5,9, 10-tetraazaperylene, pyrazine, phenazine, thiophene
Figure BDA0003545241200000088
Oxazines, phenothiazines, fluoranthenes, naphthyridines, azacarbazoles, benzocarbazoles, phenanthrolines, 1,2, 3-triazoles, 1,2, 4-triazoles, benzotriazoles, 1,2,3-
Figure BDA0003545241200000089
Oxadiazole, 1,2,4-
Figure BDA00035452412000000810
Oxadiazole, 1,2,5-
Figure BDA00035452412000000811
Oxadiazole, 1,3,4-
Figure BDA00035452412000000812
Oxadiazole, 1,2, 3-thiadiazole, 1,2, 4-thiadiazole, 1,2, 5-thiadiazole, 1,3, 4-thiadiazole, 1,3, 5-triazine, 1,2, 4-triazine, 1,2, 3-triazine, tetrazole, 1,2,4, 5-tetrazine, 1,2,3, 4-tetrazine, 1,2,3, 5-tetrazine, purine, pteridine, indolizine and benzothiadiazole, or combinations of these groups.
For the purposes of the present invention, where the individual H atoms or CH2A straight-chain alkyl group having 1 to 40C atoms or a branched or cyclic alkyl group having 3 to 40C atoms or an alkenyl or alkynyl group having 2 to 40C atoms, which group may also be substituted by the groups mentioned above under the definition of said group, is preferably considered to mean the following groups: methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, 2-methylbutyl, n-pentyl, sec-pentyl, cyclopentyl, neopentyl, n-hexyl, cyclohexyl, neohexyl, n-butyl, tert-butyl, 2-methylbutyl, neopentyl, or neopentylHeptyl, cycloheptyl, n-octyl, cyclooctyl, 2-ethylhexyl, trifluoromethyl, pentafluoroethyl, 2,2, 2-trifluoroethyl, ethenyl, propenyl, butenyl, pentenyl, cyclopentenyl, hexenyl, cyclohexenyl, heptenyl, cycloheptenyl, octenyl, cyclooctenyl, ethynyl, propynyl, butynyl, pentynyl, hexynyl, or octynyl. Alkoxy or thioalkyl radicals having 1 to 40C atoms are preferably understood to mean methoxy, trifluoromethoxy, ethoxy, n-propoxy, isopropoxy, n-butoxy, isobutoxy, sec-butoxy, tert-butoxy, n-pentyloxy, sec-pentyloxy, 2-methylbutyloxy, n-hexyloxy, cyclohexyloxy, n-heptyloxy, cycloheptyloxy, n-octyloxy, cyclooctyloxy, 2-ethylhexyloxy, pentafluoroethoxy, 2,2, 2-trifluoroethoxy, methylthio, ethylthio, n-propylthio, isopropylthio, n-butylthio, isobutylthio, sec-butylthio, tert-butylthio, n-pentylthio, sec-pentylthio, n-hexylthio, cyclohexylthio, n-heptylthio, cycloheptylthio, n-octylthio, cyclooctylthio, 2-ethylhexylthio, trifluoromethylthio, pentafluoroethylthio, 2,2, 2-trifluoroethylylthio, An ethylenethio group, a propylenylthio group, a butylenylthio group, a pentenylthio group, a cyclopentenylthio group, a hexenylthio group, a cyclohexenylthio group, a heptenylthio group, a cycloheptenylthio group, an octenylthio group, a cyclooctenylthio group, an ethynylthio group, a propynylthio group, a butynylthio group, a pentynylthio group, a hexynylthio group, a heptynylthio group or an octynylthio group.
For the purposes of the present application, the expression that two groups may form a ring with one another is intended to be taken to mean, in particular, that the two groups are linked to one another by a chemical bond. This is illustrated by the following scheme:
Figure BDA0003545241200000091
furthermore, the above expression is also intended to be taken to mean that, in the case where one of the two groups represents hydrogen, the second group is bonded at the position to which the hydrogen atom is bonded, and forms a ring.
This is illustrated by the following scheme:
Figure BDA0003545241200000101
preferably, in the presence of Y1To Y4In a six-membered ring of (2), Y4The radicals being N, Y3Radical with ArSThe radicals being bonded, thus Y3Represents C, and one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2. More preferably, Y4The radicals being N, Y3Radical with ArSThe radicals being bonded, thus Y3Represents C, Y2The radicals being N and Y1The radical represents CR2
Preferably, X1To X4The radicals, on each occurrence, being identical or different, representing CR1
According to a preferred embodiment, ArSIs a single bond, such that the compound of formula (1) corresponds to a compound of formula (1A):
Figure BDA0003545241200000102
wherein the symbols have the same meaning as described above.
According to another preferred embodiment, ArSThe radicals are aromatic or heteroaromatic ring systems having from 5 to 18 aromatic ring atoms, which may also be substituted in each case by one or more R groups.
More preferably, ArSThe radicals represent, identically or differently on each occurrence, phenyl, biphenyl, fluorene, spirobifluorene, naphthalene, phenanthrene, anthracene, dibenzofuran, dibenzothiophene, carbazole, pyridine, pyrimidine, pyrazine, pyridazine, triazine, benzopyridine, benzopyridazine, benzopyrimidine and quinazoline, each of which may be substituted by one or more R groups.
According to a very preferred embodiment, ArSThe radicals, on each occurrence, being identical or different, representing phenyl, biphenyl, fluorene, dibenzofuran, bisBenzothiophenes and carbazoles, each of which may be substituted with one or more R groups.
Suitable ArSExamples of radicals are those shown in the following table (Ar)S-1) to (Ar)S-22) a group:
Figure BDA0003545241200000111
Figure BDA0003545241200000121
wherein the dotted bond indicates a bond to the structure of formula (1), and wherein (Ar)S-1) to (Ar)S-22) the group can be substituted with an R group at each free position, and wherein:
RN0、RC0the same or different at each occurrence is: h, D, F, Cl, Br, I, CN, a linear alkyl, alkoxy or thioalkoxy group having 1 to 40, preferably 1 to 20, more preferably 1 to 10C atoms or a cyclic alkyl, alkoxy or thioalkoxy group having 3 to 40, preferably 3 to 20, more preferably 3 to 10C atoms, each of which may be substituted by one or more R groups, wherein one or more non-adjacent CH's may be present2The radicals may be replaced by (R) C ═ C (R), C ≡ C, O or S and where one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead of, or as aromatic or heteroaromatic ring systems having from 5 to 60, preferably from 5 to 40, more preferably from 5 to 30, very preferably from 5 to 18, aromatic ring atoms, which may in each case be substituted by one or more R groups, where optionally two adjacent R groupsC0The radicals can form mono-or polycyclic aliphatic, aromatic or heteroaromatic ring systems with one another.
Very suitable ArSExamples of radicals are shown in the table below (Ar)S-23) to (Ar)S-67) a group:
Figure BDA0003545241200000131
Figure BDA0003545241200000141
Figure BDA0003545241200000151
Figure BDA0003545241200000161
wherein the dotted bond indicates a bond to the structure of formula (1), and wherein (Ar)S-23) to (Ar)S-67) the group can be substituted with an R group in each free position.
Preferably, RNA radical denotes an aromatic or heteroaromatic ring system having from 5 to 60, preferably from 5 to 40, more preferably from 5 to 24, very preferably from 6 to 18, aromatic ring atoms, which ring system may be substituted in each case by one or more R groups.
More preferably, RNThe radicals, on each occurrence, being identical or different, represent: phenyl, biphenyl, terphenyl, quaterphenyl, fluorene, spirobifluorene, naphthalene, anthracene, phenanthrene, terphenyl, fluoranthene, indole, benzofuran, benzothiophene, dibenzofuran, dibenzothiophene, carbazole, indenocarbazole, indolocarbazole, phenanthroline, pyridine, pyrimidine, pyrazine, pyridazine, triazine, quinolone, benzopyridine, benzopyridazine, benzopyrimidine, quinazoline, benzimidazole, or a combination of two or three of these groups, each of which may be substituted with one or more R groups.
Very suitable RNExamples of radicals are the radicals of the formulae (RN-1) to (RN-22) shown in the following table:
Figure BDA0003545241200000162
Figure BDA0003545241200000171
Figure BDA0003545241200000181
wherein:
-the dashed bond indicates the bond to the nitrogen group of the lactam ring in formula (1);
-RC0and RN0The radicals have the same meanings as described above; and is
The radicals of the formulae (RN-1) to (RN-22) may be substituted by an R radical in each free position.
Among the groups of formulae (RN-1) to (RN-22), preferred are the groups of formulae (RN-1), (RN-2), (RN-3), (RN-4), (RN-5), (RN-6), (RN-7), (RN-8), (RN-9) and (RN-10).
According to a preferred embodiment, the compound of formula (1) is selected from the compounds of formulae (2) to (13),
Figure BDA0003545241200000191
Figure BDA0003545241200000201
Figure BDA0003545241200000211
wherein
-symbol X1-X4、ArSAnd RNHave the same meanings as described above;
-Z1-Z12at each occurrence, identically or differently representing CR3Or N;
-in formulae (2), (3), (6) and (7), selected from Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z9-Z10、Z10-Z11And Z11-Z12At least two adjacent Z groups together form an aromatic ring of formula (Aro-1) as defined in claim 1;
-in formulae (4), (5), (8) and (9), selected from Z1-Z2、Z2-Z3、Z3-Z4、Z7-Z8、Z9-Z10、Z10-Z11And Z11-Z12At least two adjacent Z groups together form an aromatic ring of formula (Aro-1) as defined in claim 1; and wherein
-in formulae (10), (11), (12) and (13), selected from Z1-Z2、Z2-Z3、Z3-Z4、Z9-Z10、Z10-Z11And Z11-Z12At least two adjacent Z groups together form an aromatic ring of formula (Aro-1) as defined in claim 1;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
According to a very preferred embodiment, the compound of formula (1) is selected from compounds of formulae (2-1) to (2-7) or (3-1) to (3-7),
Figure BDA0003545241200000221
Figure BDA0003545241200000231
Figure BDA0003545241200000241
Figure BDA0003545241200000251
wherein
X1-X4、ArS、R3And RNHave the same meanings as described above;
one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
p is an integer of 0 to 2;
m is an integer of 0 to 4; and is
n is an integer of 0 to 6.
According to another very preferred embodiment, the compound of formula (1) is selected from compounds of formulae (4-1) to (4-7) or (5-1) to (5-7),
Figure BDA0003545241200000261
Figure BDA0003545241200000271
Figure BDA0003545241200000281
Figure BDA0003545241200000291
wherein
X1-X4、ArS、R3And RNHave the same meanings as described above;
one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
p is an integer of 0 to 2;
m is an integer of 0 to 4; and is
n is an integer of 0 to 6.
According to another very preferred embodiment, the compound of formula (1) is selected from compounds of formulae (6-1) to (6-7) or (7-1) to (7-7),
Figure BDA0003545241200000301
Figure BDA0003545241200000311
Figure BDA0003545241200000321
Figure BDA0003545241200000331
wherein
-X1-X4、ArS、R3And RNHave the same meanings as described above;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
According to yet another very preferred embodiment, the compound of formula (1) is selected from compounds of formulae (8-1) to (8-7) or (9-1) to (9-7),
Figure BDA0003545241200000341
Figure BDA0003545241200000351
Figure BDA0003545241200000361
Figure BDA0003545241200000371
wherein
-X1-X4、ArS、R3And RNHave the same meanings as described above;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
According to yet another very preferred embodiment, the compound of formula (1) is selected from compounds of formulae (10-1) to (10-6) or (11-1) to (11-6),
Figure BDA0003545241200000381
Figure BDA0003545241200000391
Figure BDA0003545241200000401
Figure BDA0003545241200000411
wherein
-X1-X4、ArS、R3And RNHave the same meanings as described above;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
According to another very preferred embodiment, the compound of formula (1) is selected from compounds of formulae (12-1) to (12-6) or (13-1) to (13-6),
Figure BDA0003545241200000421
Figure BDA0003545241200000431
Figure BDA0003545241200000441
wherein
-X1-X4、ArS、R3And RNHave the same meanings as described above;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
According to a particularly preferred embodiment, the compound of formula (1) is selected from compounds of formulae (2-1a) to (2-7a) or (3-1a) to (3-7a),
Figure BDA0003545241200000451
Figure BDA0003545241200000461
Figure BDA0003545241200000471
Figure BDA0003545241200000481
wherein R is1、R2、R3And RNHave the same meanings as described above.
According to another particularly preferred embodiment, the compound of formula (1) is selected from compounds of formulae (4-1a) to (4-7a) or (5-1a) to (5-7a),
Figure BDA0003545241200000491
Figure BDA0003545241200000501
Figure BDA0003545241200000511
Figure BDA0003545241200000521
wherein R is1、R2、R3And RNHave the same meanings as described above.
According to another particularly preferred embodiment, the compound of formula (1) is selected from compounds of formulae (6-1a) to (6-7a) or (7-1a) to (7-7a),
Figure BDA0003545241200000531
Figure BDA0003545241200000541
Figure BDA0003545241200000551
wherein R is1、R2、R3And RNHave the same meanings as described above.
According to yet another particularly preferred embodiment, the compound of formula (1) is selected from compounds of formulae (8-1a) to (8-7a) or (9-1a) to (9-7a),
Figure BDA0003545241200000561
Figure BDA0003545241200000571
Figure BDA0003545241200000581
Figure BDA0003545241200000591
wherein R is1、R2、R3And RNHave the same meanings as described above.
According to yet another particularly preferred embodiment, the compound of formula (1) is selected from compounds of formulae (10-1a) to (10-6a) or (11-1a) to (11-6a),
Figure BDA0003545241200000601
Figure BDA0003545241200000611
Figure BDA0003545241200000621
wherein R is1、R2、R3And RNHave the same meanings as described above.
According to another very preferred embodiment, the compound of formula (1) is selected from compounds of formulae (12-1a) to (12-6a) or (13-1a) to (13-6a),
Figure BDA0003545241200000631
Figure BDA0003545241200000641
Figure BDA0003545241200000651
wherein R is1、R2、R3And RNHave the same meanings as described above.
Preferably, R1、R3On each occurrence, the same or different indicates: h, D, F, CN, a straight-chain alkyl radical having 1 to 20C atoms or a branched or cyclic alkyl radical having 3 to 20C atoms, which radicals may each be substituted by one or more R radicals, where in each case one or more non-adjacent CH radicals2Radicals may be replaced by RC ═ CR, C ≡ C, O or S and where one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, aromatic or heteroaromatic ring systems having from 5 to 40, preferably from 5 to 30, more preferably from 5 to 18, aromatic ring atoms, which may be substituted in each case by one or more R groups, or aryloxy groups having from 5 to 40, preferably from 5 to 30, more preferably from 5 to 18, aromatic ring atoms, which may be substituted by one or more R groups, where two R groups1The radicals can form mono-or polycyclic, aliphatic, aromatic or heteroaromatic ring systems with one another, which may be substituted by one or more R groups, and where two R groups3The radicals may form a single ring with one another orPolycyclic aliphatic, aromatic or heteroaromatic ring systems, which may be substituted by one or more R groups. When two R are1Or R3When the groups form a ring, they preferably form a condensed benzene ring as exemplified below:
Figure BDA0003545241200000661
more preferably, R1、R3On each occurrence, the same or different indicates: h, D, CN, a straight-chain alkyl radical having 1 to 10C atoms or a branched or cyclic alkyl radical having 3 to 10C atoms, each of which may be substituted by one or more R groups, an aromatic or heteroaromatic ring system having 5 to 18 aromatic ring atoms, which may be substituted in each case by one or more R groups, where two R groups1The radicals can form a condensed benzene ring with one another, which may be substituted by one or more R groups, and where two R groups3The groups may form condensed benzene rings with each other, which may be substituted with one or more R groups.
Preferably, R2On each occurrence, the same or different indicates: h, D, F, a straight-chain alkyl radical having 1 to 20C atoms or a branched or cyclic alkyl radical having 3 to 20C atoms, which radicals may each be substituted by one or more R radicals, where in each case one or more non-adjacent CH radicals2The radicals may be replaced by RC ═ CR, C ≡ C, O or S and where one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, aromatic or heteroaromatic ring systems having from 5 to 40, preferably from 5 to 30, more preferably from 5 to 18, aromatic ring atoms, which may be substituted in each case by one or more R groups, or aryloxy groups having from 5 to 40, preferably from 5 to 30, more preferably from 5 to 18, aromatic ring atoms, which may be substituted by one or more R groups.
More preferably, R2On each occurrence, the same or different indicates: h, D, F, a straight-chain alkyl group having 1 to 10C atoms or a branched or cyclic alkyl group having 3 to 10C atomsA group, which each may be substituted by one or more R groups, or an aromatic or heteroaromatic ring system having from 5 to 60, preferably from 5 to 40, more preferably from 5 to 30, very preferably from 5 to 18, aromatic ring atoms, which may in each case be substituted by one or more R groups.
Very preferably, R2On each occurrence, identically or differently, denotes an aromatic or heteroaromatic ring system having from 5 to 60, preferably from 5 to 40, more preferably from 5 to 30, very preferably from 5 to 18, aromatic ring atoms, which may be substituted in each case by one or more R groups.
Particularly preferably, R2Represents an aromatic or heteroaromatic ring system selected from: benzene, naphthalene, anthracene, benzanthracene, phenanthrene, terphenylene (also known as triphenylene), pyrene, chicory, perylene, fluoranthene, tetracene, pentacene, benzopyrene, biphenyl, dibenzylidene, terphenyl, terphenylene, tetrabiphenyl, fluorene, spirobifluorene, indenofluorene, furan, benzofuran, dibenzofuran, thiophene, benzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carbazole, indolocarbazole, indenocarbazole, pyridine, quinoline, isoquinoline, acridine, phenanthridine, benzoquinoline, phenothiazine, thiophene
Figure BDA0003545241200000671
Oxazines, imidazoles, benzimidazoles, naphthoimidazoles, phenanthroimidazoles, pyrimidines, benzopyrimidines, quinoxalines, pyrazines, phenazines, thiophenes
Figure BDA0003545241200000672
Oxazines, phenothiazines, azacarbazoles, triazines, or combinations of these groups. Very particularly preferably, R2The groups are selected from the following: benzene, naphthalene, phenanthrene, terphenylene, fluoranthene, biphenyl, terphenyl, quaterphenyl, fluorene, spirobifluorene, indenofluorene, dibenzofuran, dibenzothiophene, carbazole, indolocarbazole, indenocarbazole, pyridine, quinoline, benzoquinoline, pyrimidine, benzopyrimidine, quinoxaline, thiophene
Figure BDA0003545241200000673
Oxazines, phenothiazines, azacarbazoles,Pyrazine, triazine or combinations of these groups.
Preferably, R, on each occurrence, represents, identically or differently: h, D, F, CN, a linear alkyl or alkoxy group having 1 to 20C atoms or a branched or cyclic alkyl or alkoxy group having 3 to 20C atoms, which groups may each be substituted by one or more R ' groups, an aromatic or heteroaromatic ring system having 5 to 40, preferably 5 to 30, more preferably 5 to 18 aromatic ring atoms, which ring system may in each case be substituted by one or more R ' groups, wherein two R groups may form a ring with one another, which ring may be substituted by one or more R ' groups. More preferably, R, on each occurrence, represents, identically or differently: h, D, F, CN, a straight-chain alkyl group having 1 to 10C atoms or a branched or cyclic alkyl group having 3 to 10C atoms, which groups may each be substituted by one or more R 'groups, an aromatic or heteroaromatic ring system having 5 to 18 aromatic ring atoms, which ring system may in each case be substituted by one or more R' groups.
Preferably, Ar is an aromatic or heteroaromatic ring system having from 5 to 18 aromatic ring atoms, which ring system may also be substituted in each case by one or more R' groups.
Preferably, R', at each occurrence, represents, identically or differently: h, D, F, Cl, Br, I, CN, a linear alkyl or alkoxy group having 1 to 20, preferably 1 to 10, more preferably 1 to 5C atoms or a branched or cyclic alkyl or alkoxy group having 3 to 20, preferably 1 to 10, more preferably 1 to 5C atoms, wherein one or more H atoms may be substituted by D, F, Cl, Br or I, or an aromatic or heteroaromatic ring system having 5 to 24C atoms, preferably 5 to 18C atoms.
Examples of suitable compounds of the present invention are the structures shown in the following table:
Figure BDA0003545241200000681
Figure BDA0003545241200000691
Figure BDA0003545241200000701
Figure BDA0003545241200000711
Figure BDA0003545241200000721
Figure BDA0003545241200000731
Figure BDA0003545241200000741
Figure BDA0003545241200000751
the compounds of the invention can be prepared by synthetic procedures known to those skilled in the art, such as bromination, Suzuki coupling, Ullmann coupling, Hartwig-Buchwald coupling, and the like. Examples of suitable synthetic methods are depicted generally in schemes 1-3.
Scheme 1
Figure BDA0003545241200000761
Scheme 2
Figure BDA0003545241200000762
Scheme 3
Figure BDA0003545241200000771
In schemes 1,2 and 3:
X1、X2(ii) a leaving group, more preferably halogen
Quin ═ quinazoline or quinoxaline derivatives
Ar ═ aromatic or heteroaromatic ring systems
Ar1、Ar2And Ar3An aromatic or heteroaromatic ring system.
Furthermore, the compounds shown in the above schemes may be substituted at any free position with any organic group.
Accordingly, the present invention relates to a method of synthesizing a compound of the present invention, said method comprising:
(i) synthesizing a polycyclic compound comprising at least three aryl or heteroaryl groups, wherein two aryl or heteroaryl groups are linked via a six-membered lactam ring and two aryl or heteroaryl groups are linked via a pyrrole ring;
(ii) (ii) introducing a quinazoline or quinoxaline group by a C-N coupling reaction between the nitrogen atom of the compound obtained in step (i) and the quinazoline or quinoxaline group.
Accordingly, the present invention relates to a further process for the synthesis of a compound of the invention, said process comprising:
(i) a C-C coupling reaction between a carbazole derivative comprising a quinazoline or quinoxaline group and an aryl or heteroaryl group;
(ii) (ii) forming a lactam bridge between the carbazole derivative of step (i) and the aryl or heteroaryl group.
In order to process the compounds of the invention from the liquid phase, for example by spin coating or by printing methods, a formulation of the compounds of the invention is required. These formulations may be, for example, solutions, dispersions or emulsions. For this purpose, mixtures of two or more solvents can preferably be used. The solvent is preferably selected from organic and inorganic solvents, more preferably an organic solvent. The solvent is very preferably selected from the group consisting of hydrocarbons, alcohols, esters, ethers, ketones and amines. A suitable and preferred solvent is, for example, tolueneAnisole, o-, m-or p-xylene, methyl benzoate, mesitylene, tetralin, o-dimethoxybenzene, THF, methyl-THF, THP, chlorobenzene, dioxane
Figure BDA0003545241200000781
Alkanes, phenoxytoluenes, in particular 3-phenoxytoluene, (-) -fenchone, 1,2,3, 5-tetramethylbenzene, 1,2,4, 5-tetramethylbenzene, 1-methylnaphthalene, 1-ethylnaphthalene, decylbenzene, phenylnaphthalene, menthyl isovalerate, p-tolylisobutyrate, cyclohexylhexanoate, ethyl p-toluate, ethyl o-toluate, ethyl m-toluate, decalin, ethyl 2-methoxybenzoate, dibutylaniline, dicyclohexylketone, isosorbide dimethyl ether, decalin, 2-methylbiphenyl, ethyl octanoate, octyl octanoate, diethyl sebacate, 3, 3-dimethylbiphenyl, 1, 4-dimethylnaphthalene, 2, 2' -dimethylbiphenyl, 2-methylbenzothiazole, 2-phenoxyethanol, 2-pyrrolidone, 3-methylanisole, 4-methylanisole, 3, 4-dimethylanisole, 3, 5-dimethylanisole, acetophenone, α -terpineol, benzothiazole, butyl benzoate, cumene, cyclohexanol, cyclohexanone, cyclohexylbenzene, decalin, dodecylbenzene, ethyl benzoate, indane, NMP, p-cymene, phenetole, 1, 4-diisopropylbenzene, dibenzyl ether, diethylene glycol butyl methyl ether, triethylene glycol butyl methyl ether, diethylene glycol dibutyl ether, triethylene glycol dimethyl ether, diethylene glycol monobutyl ether, tripropylene glycol dimethyl ether, tetraethylene glycol dimethyl ether, 2-isopropylnaphthalene, pentylbenzene, hexylbenzene, heptylbenzene, octylbenzene, 1, 1-bis (3, 4-dimethylphenyl) ethane, or a mixture of these solvents.
Thus, the invention also relates to a formulation comprising a compound of the invention and at least one other compound. The further compound may be, for example, a solvent, in particular one of the solvents mentioned above or a mixture of these solvents. However, the further compound may also be at least one of other organic or inorganic compounds which are likewise used in electronic devices, for example a luminescent compound, in particular a phosphorescent dopant, and/or other matrix materials. Suitable light-emitting compounds and other matrix materials are indicated below in connection with organic electroluminescent devices. The other compounds may also be polymeric.
The compounds and mixtures of the invention are suitable for use in electronic devices. Electronic devices are herein understood to mean devices comprising at least one layer containing at least one organic compound. However, the elements may also comprise inorganic materials here or may also comprise layers built up entirely from inorganic materials.
The invention therefore also relates to the use of the compounds or mixtures according to the invention in electronic devices, in particular in organic electroluminescent devices.
The invention furthermore relates to electronic devices comprising at least one of the above-described compounds or mixtures according to the invention. The preferences stated above for the compounds also apply to the electronic device.
The electronic device is preferably selected from the group consisting of organic electroluminescent devices (OLED, PLED), organic integrated circuits (O-IC), organic field effect transistors (O-FET), organic thin film transistors (O-TFT), organic light emitting transistors (O-LET), organic solar cells (O-SC), organic dye sensitized solar cells, organic optical detectors, organic photoreceptors, organic field quenching devices (O-FQD), light emitting electrochemical cells (LEC), organic laser diodes (O-laser) and "organic plasma light emitting devices" (d.m. koller et al, Nature Photonics, 2008, 1-4), preferably organic electroluminescent devices (OLED, PLED), in particular phosphorescent OLEDs.
The organic electroluminescent device comprises a cathode, an anode and at least one light-emitting layer. In addition to these layers, it may also comprise further layers, for example in each case one or more hole-injecting layers, hole-transporting layers, hole-blocking layers, electron-transporting layers, electron-injecting layers, exciton-blocking layers, electron-blocking layers and/or charge-generating layers. It is likewise possible to introduce an intermediate layer having, for example, an exciton blocking function between the two light-emitting layers. However, it should be noted that each of these layers need not necessarily be present. The organic electroluminescent device may here comprise one light-emitting layer or a plurality of light-emitting layers. If a plurality of light-emitting layers are present, these preferably have a plurality of emission peaks generally between 380nm and 750nm, so that the overall result is white emission, i.e., a plurality of light-emitting compounds capable of fluorescence or phosphorescence are used in the light-emitting layers. Particularly preferred are systems with three light-emitting layers, wherein the three layers exhibit blue, green and orange or red emission (see for example WO 2005/011013 for basic structures). These may be fluorescent or phosphorescent light-emitting layers, or mixed systems in which fluorescent and phosphorescent light-emitting layers are combined with one another.
Depending on the exact structure, the compounds of the invention according to the embodiments indicated above can be used in different layers. Preferred are organic electroluminescent devices as described below: which comprise the compounds of the formula (1) or according to the preferred embodiments in the light-emitting layer as matrix materials for fluorescent emitters, phosphorescent emitters or emitters which exhibit TADF (thermally excited delayed fluorescence), in particular phosphorescent emitters, and/or, depending on the exact substitution, in the electron transport layer and/or in the electron-blocking layer or exciton-blocking layer and/or in the hole transport layer. The preferred embodiments indicated above are also suitable for the use of the materials in organic electronic devices.
In a preferred embodiment of the present invention, the compounds of the formula (1) or according to the preferred embodiment are used as matrix materials for fluorescent or phosphorescent compounds, in particular phosphorescent compounds, in the light-emitting layer. The organic electroluminescent devices here may comprise a light-emitting layer or a plurality of light-emitting layers, wherein at least one light-emitting layer comprises at least one compound according to the invention as matrix material.
If the compound of the formula (1) or according to the preferred embodiment is used as a matrix material for a light-emitting compound in a light-emitting layer, it is preferably used in combination with one or more phosphorescent materials (triplet emitters). Phosphorescence in the sense of the present invention is understood to mean light emission from an excited state with a spin multiplicities >1, in particular from an excited triplet state. For the purposes of the present application, all luminescent transition metal complexes or luminescent lanthanide complexes, in particular all iridium, platinum and copper complexes, are to be regarded as phosphorescent compounds.
Preferably, when the compounds of the formula (1) or according to the preferred embodiments are used as matrix materials for light-emitting compounds in light-emitting layers, they are preferably used in combination with one or more phosphorescent materials (triplet emitters).
The mixture comprising the compound of the formula (1) or according to the preferred embodiment and the luminescent compound comprises between 99% and 1% by volume, preferably between 98% and 10% by volume, particularly preferably between 97% and 60% by volume, in particular between 95% and 80% by volume of the compound of the formula (1) or according to the preferred embodiment, based on the entire mixture comprising the emitter and the matrix material. Accordingly, the mixture comprises between 1% and 99% by volume, preferably between 2% and 90% by volume, particularly preferably between 3% and 40% by volume, in particular between 5% and 20% by volume, of luminophores, based on the total mixture comprising luminophores and matrix material.
Suitable phosphorescent compounds (═ triplet emitters) are in particular the following compounds: which emits light when appropriately excited, preferably in the visible region, and also contains at least one atom having an atomic number of greater than 20, preferably greater than 38 and less than 84, particularly preferably greater than 56 and less than 80, in particular a metal having this atomic number. The phosphorescent emitters used are preferably compounds containing copper, molybdenum, tungsten, rhenium, ruthenium, osmium, rhodium, iridium, palladium, platinum, silver, gold or europium, in particular compounds containing iridium or platinum. For the purposes of the present invention, all luminescent compounds containing the above-mentioned metals are considered to be phosphorescent compounds.
The following applications disclose examples of such emitters: WO 00/70655, WO 2001/41512, WO 2002/02714, WO 2002/15645, EP 1191613, EP 1191612, EP 1191614, WO 05/033244, WO 05/019373, US 2005/0258742, WO 2009/146770, WO 2010/015307, WO 2010/031485, WO 2010/054731, WO 2010/054728, WO 2010/086089, WO 2010/099852, WO 2010/102709, WO 2011/032626, WO 2011/066898, WO 2011/157339, WO 2012/007086, WO 2014/008982, WO 2014/023377, WO 2014/094962, WO 2014/094961, WO 2014/094960, WO 2016/124304, WO 2016/125715, WO 2017/032439, as well as the unpublished applications WO 2018/011186 and WO 2018/041769. In general, all phosphorescent complexes which are used in accordance with the prior art for phosphorescent OLEDs and are known to the person skilled in the art of organic electroluminescence are suitable, and the person skilled in the art is able to use further phosphorescent complexes without inventive effort.
Examples of suitable phosphorescent emitters are the phosphorescent emitters listed in the following table:
Figure BDA0003545241200000821
Figure BDA0003545241200000831
Figure BDA0003545241200000841
Figure BDA0003545241200000851
Figure BDA0003545241200000861
Figure BDA0003545241200000871
Figure BDA0003545241200000881
as mentioned above, suitable phosphorescent materials that can be advantageously combined with said compounds of formula (1) (═ triplet emitters) are compounds that emit red light under appropriate excitation, which means that the excited triplet level (T1) of the phosphorescent material is between 550nm and 800nm, more particularly between 550nm and 680 nm.
Another preferred embodiment of the present invention is the use of the compounds of the formula (1) or according to the preferred embodiments in combination with other matrix materials as matrix materials for phosphorescent emitters. Particularly suitable matrix materials which can be used in combination with the compounds of the formula (1) or according to the preferred embodiments are, for example, aromatic ketones, aromatic phosphine oxides or aromatic sulfoxides or sulfones according to WO 2004/013080, WO 2004/093207, WO 2006/005627 or WO 2010/006680; triarylamines, carbazole derivatives, such as CBP (N, N-biscarbazolylbiphenyl) or carbazole derivatives disclosed in WO 2005/039246, US 2005/0069729, JP 2004/288381, EP 1205527 or WO 2008/086851; indolocarbazole derivatives, for example according to WO 2007/063754 or WO 2008/056746; indenocarbazole derivatives, for example according to WO 2010/136109 and WO 2011/000455; azacarbazole derivatives, for example according to EP 1617710, EP 1617711, EP 1731584, JP 2005/347160; bipolar matrix materials, for example according to WO 2007/137725; for example silanes according to WO 005/111172; for example azaborol or boronate according to WO 2006/117052; triazine derivatives, for example according to WO 2010/015306, WO 2007/063754 or WO 2008/056746; zinc complexes, for example according to EP 652273 or WO 2009/062578; for example diazasilacyclopentadiene or tetraazasilacyclopentadiene derivatives according to WO 2010/054729; diazaphosphole derivatives, for example according to WO 2010/054730; for example bridged carbazole derivatives according to US 2009/0136779, WO 2010/050778, WO 2011/042107, WO 2011/088877 or according to EP 11003232.3; for example a terphenyl fork derivative according to WO 2012/048781; or lactams, for example according to WO 2011/116865 or WO 2011/137951. Likewise, a further phosphorescent emitter having an emission wavelength shorter than the actual emitter may also be present as a co-host in the mixture.
Preferred co-host materials are triarylamine derivatives, lactams, carbazole derivatives, and indenocarbazole derivatives. Preferred co-host materials are very particularly carbazole derivatives and indenocarbazole derivatives.
The compounds of the formula (1) or according to the preferred embodiments are particularly suitable as matrix materials alone or in combination with other matrix materials of phosphorescent emitters.
In another embodiment of the present invention, the organic electroluminescent device of the present invention does not comprise a separate hole injection layer and/or hole transport layer and/or hole blocking layer and/or electron transport layer, i.e. the light-emitting layer is directly adjacent to the hole injection layer or the anode and/or the light-emitting layer is directly adjacent to the electron transport layer or the electron injection layer or the cathode, for example as described in WO 2005/053051. It is also possible to use the same or similar metal complex as that in the light-emitting layer as the hole-transporting or hole-injecting material directly adjacent to the light-emitting layer, for example as described in WO 2009/030981.
The compounds of the invention can also be used in hole blocking layers or electron transport layers. This applies in particular to the compounds of the invention which do not have a carbazole structure. These compounds may also preferably be substituted with one or more other electron transport groups, such as a benzimidazole group.
In the other layers of the organic electroluminescent device of the present invention, any material generally used in the art may be used. The person skilled in the art is therefore able to use any material known for use in organic electroluminescent devices in combination with the compounds of the formula (1) or the preferred embodiments without inventive effort.
For example, the compounds of the present invention may also be used as a host for semiconductor light-emitting nanoparticles. In the context of the present invention, the term "nano" means in the size range from 0.1nm to 999nm, preferably from 1nm to 150 nm. In a preferred embodiment, the semiconductor luminescent nanoparticles are quantum materials ("quantum sized materials"). The term "quantum material" in the sense of the present invention refers to the size of the semiconductor material itself without further connection or further surface modification, which shows the so-called quantum confinement effect, as described for example in ISBN 978-3-662-44822-9. In one embodiment of the invention, the total size of the quantum material is in the range of 1nm to 100nm, more preferably 1nm to 30nm, particularly preferably 5nm to 15 nm. In this case, the core of the semiconductor luminescent nanoparticle may vary. Suitable examples are CdS, CdSe, CdTe, ZnS, ZnSe, ZnSeS、ZnTe、ZnO、GaAs、GaP、GaSb、HgS、HgSe、HgSe、HgTe、InAs、InP、InPS、InPZnS、InPZn、InPGa、InSb、AlAs、AlP、AlSb、Cu2S、Cu2Se、CuInS2、CuInSe2、Cu2(ZnSn)S4、Cu2(InGa)S4、TiO2Or a combination of said materials. In a preferred embodiment, the core of the semiconductor light-emitting particle contains one or more elements of group 13 and one or more elements of group 15 of the periodic system of elements, such as GaAs, GaP, GaSb, InAs, InP zns, InP zn, InP ga, InSb, AlAs, AlP, AlSb, CuInS2、CuInSe2、Cu2(InGa)S4Or combinations of the mentioned materials. Particularly preferably, the core contains In atoms and P atoms, such as InP, InP zns, InP zn or InP ga. In another embodiment of the invention, the nanoparticle contains one or more shell layers comprising a first element from group 12, 13 or 14 of the periodic table and a second element from group 15 or 16 of the periodic table. Preferably, all shell layers contain a first element from group 12, 13 or 14 of the periodic system and a second element from group 15 or 16 of the periodic system. In a preferred embodiment of the invention, at least one of the shell layers contains a first element from group 12 and a second element from group 16 of the periodic table, such as CdS, CdZnS, ZnS, ZnSe, ZnSSe, ZnSSeTe, CdS/ZnS, ZnSe/ZnS or ZnS/ZnSe. Particularly preferably, all shell layers contain a first element from group 12 and a second element from group 16 of the periodic table.
Also preferred are organic electroluminescent devices which are characterized in that one or more layers are applied by a sublimation process in which less than 10 times are present in a vacuum sublimation apparatus-5Mbar, preferably less than 10-6The material was vacuum deposited at an initial pressure of mbar. However, the initial pressure may also be even lower or higher, e.g. less than 10-7Millibar.
Also preferred are organic electroluminescent devices which are characterized by being produced by the OVPD (organic vapor deposition) method or by means of a carrierGas sublimation is applied to one or more layers, where 10-5The material is applied at a pressure between mbar and 1 bar. One special case of this method is the OVJP (organic vapor jet printing) method, in which the material is applied directly through a nozzle and is structured thereby (for example m.s. arnold et al, appl.phys.lett.2008, 92, 053301).
Also preferred are organic electroluminescent devices which are characterized in that one or more layers are produced from solution, for example by spin coating, or by any desired printing method, for example ink-jet printing, LITI (photo-induced thermal imaging, thermal transfer), screen printing, flexographic printing, offset printing, or nozzle printing. For this purpose, soluble compounds are required, which are obtained, for example, by appropriate substitution.
Hybrid methods are also possible, for example, in which one or more layers are applied from solution and one or more other layers are applied by vapor deposition. Thus, for example, the light-emitting layer may be applied from solution and the electron-transporting layer applied by vapor deposition.
These methods are generally known to the person skilled in the art and can be applied without inventive effort to the organic electroluminescent devices comprising the compounds according to the invention.
The compounds according to the invention generally have very good properties when used in organic electroluminescent devices. In particular, the lifetime is significantly better when the compounds according to the invention are used in organic electroluminescent devices than comparable compounds according to the prior art. Other properties of the organic electroluminescent device, in particular efficiency and voltage, are equally better or at least comparable. In addition, the compounds have high glass transition temperatures and high thermal stability.
The invention will now be illustrated in more detail by the following examples, without wishing to limit the invention thereto.
A) Synthesis example
Unless otherwise stated, the following syntheses were carried out in dry solvents under a protective gas atmosphere. The compounds of the present invention can be synthesized by synthetic methods known to those skilled in the art.
a)5- (2-Chloroanilino) benzo [ c ] fluoren-7-one
Figure BDA0003545241200000921
43g (140mmol) of 5-bromobenzo [ c ] fluoren-7-one, 17.9g (140mmol) of 2-chloroaniline, 68.2g (710mmol) of sodium tert-butoxide, 613mg (3mmol) of palladium (II) acetate and 3.03g (5mmol) of dppf were dissolved in 1.3L of toluene and stirred at reflux for 5 hours. The reaction mixture was cooled to room temperature, mixed with toluene and filtered through celite. The filtrate was concentrated in vacuo and the residue of toluene/heptane was crystallized. The product was isolated as a colorless solid. Yield: 38g (107mmol), 77% of theory.
The following compounds can be made analogously:
Figure BDA0003545241200000931
Figure BDA0003545241200000941
b) cyclization of
Figure BDA0003545241200000942
36.2g (102mmol) of 5- (2-chloroanilino) benzo [ c ] fluoren-7-one, 56g (409mmol) of potassium carbonate, 4.5g (12mmol) of tricyclohexylphosphine tetrafluoroborate and 1.38g (6mmol) of palladium (II) acetate are suspended in 500ml of dimethylacetamide and stirred under reflux for 6 hours. After cooling, the reaction mixture was mixed with 300ml of water and 400ml and stirred for 30 minutes. The organic phase was then separated and filtered through a short bed of celite. The solvent was then removed in vacuo. The crude product was extracted by thermal extraction with toluene and recrystallized from toluene. The product was isolated as a beige solid (21g, 66mmol, corresponding to 65% of theory).
The following compounds can be made analogously:
Figure BDA0003545241200000943
Figure BDA0003545241200000951
Figure BDA0003545241200000961
c)5- (2-nitrophenyl) benzo [ c ] fluoren-7-one
Figure BDA0003545241200000962
30g (183.8mmol) of B- (2-nitrophenyl) -phenylboronic acid, 57g (184mmol) of 5-bromobenzo [ c ]]A thoroughly stirred degassed suspension of fluoren-7-one and 66.5g (212.7mmol) potassium carbonate in a mixture of 250ml water and 250ml THF was mixed with 1.7g (1.49mmol) Pd (PPh)3)4Mixed and heated at reflux for 17 hours. After cooling, the organic phase is separated, washed 3 times with 200ml of water, 1 time with 200ml of saturated saline solution, dried over magnesium sulfate and spun to dryness. The grey residue was recrystallized from hexane. The precipitated crystals were extracted, washed with MeOH and dried in vacuo; yield 58.9g (167mmol), 91% of theory.
The following compounds can be made analogously:
Figure BDA0003545241200000963
Figure BDA0003545241200000971
d) carbazole synthesis
Figure BDA0003545241200000981
A mixture of 84.2g (240mmol) of 5- (2-nitrophenyl) benzo [ c ] fluoren-7-one and 290.3ml (1669mmol) of triethyl phosphite is heated at reflux for 12 hours. The remaining triethyl phosphite was then distilled off (72-76 ℃ C./9 mmHg). To the residue was added a mixture of water/MeOH (1:1), followed by filtration and recrystallization.
Yield: 53.5g (168mmol), 70% of theory.
The following compounds can be made analogously:
Figure BDA0003545241200000982
Figure BDA0003545241200000991
e)2- [11- (4-Phenylquinazolin-2-yl) benzo [ a ] carbazol-5-yl ] benzoic acid methyl ester
Figure BDA0003545241200000992
35g (70mmol) of 5-bromo-11- (4-phenylquinazolin-2-yl) benzo [ a ] carbazole, 13.4g (75mmol) of (2-methoxycarbonylphenyl) boronic acid and 14.7g (139mmol) of sodium carbonate were suspended in 200mL of toluene, 52mL of ethanol and 100mL of water. Then, 80mg (0.69mmol) tetraphenylphosphine-palladium (0) were added to the suspension and the reaction mixture was heated at reflux for 16 h. After cooling, the organic phase is separated, filtered through silica gel, washed three times with 200mL of water and then concentrated to dryness. The residue was recrystallized from heptane/dichloromethane.
The yield was 31.8g (57mmol), corresponding to 81% of theory.
The following compounds can be made analogously:
Figure BDA0003545241200001001
Figure BDA0003545241200001011
f) ketone synthesis:
Figure BDA0003545241200001021
24.4g (44mmol) of 2- [11- (4-phenylquinazolin-2-yl) benzo [ a ]]Carbazol-5-yl]Introduction of methyl benzoate into 220ml of concentrated H2SO4Neutralized and stirred for 2 hours. When the reaction was complete, the mixture was carefully poured onto ice and extracted with toluene, separated and concentrated with a rotary evaporator, the precipitated solid was aspirated off, washed with water and ethanol.
The yield was 18.8g (36mmol), corresponding to 82% of theory.
The following compounds can be prepared analogously:
Figure BDA0003545241200001022
Figure BDA0003545241200001031
Figure BDA0003545241200001041
g) ketoxime synthesis
Figure BDA0003545241200001042
76.8g (147mmol) of compound (f) were introduced into 300ml of pyridine/200 ml of methanol. Then, 20.5g hydroxylammonium chloride was slowly added to the mixture and heated at 60 ℃ for 3.5 hours. When the reaction was complete, the precipitated solid was aspirated, washed with water and 1mol of HCl, then with methanol.
The yield was 71g (132mmol), corresponding to 90% of theory.
The following compounds can be prepared analogously:
Figure BDA0003545241200001051
Figure BDA0003545241200001061
Figure BDA0003545241200001071
Figure BDA0003545241200001081
h) lactam synthesis (Beckmann rearrangement)
Figure BDA0003545241200001082
75g (141mmol) of the compound (g) are placed in 300ml of polyphosphoric acid and heated to 170 ℃ for 12 hours. When the reaction was complete, the mixture was placed on ice and extracted with ethyl acetic acid, separated and concentrated. The precipitated solid was aspirated and washed with ethanol.
The isomers were separated by chromatography.
Yield: 70g (130mmol) of a mixture h (a) + h (b), corresponding to 94% of theory, the purity by HPLC: 98.0 percent. After recrystallization from ethyl acetate/toluene (1: 2): 32g (43%) of i (a) and 38g (51.6%) of i (b) are obtained.
The following compounds can be prepared analogously:
Figure BDA0003545241200001091
Figure BDA0003545241200001101
Figure BDA0003545241200001111
j) ullmann reaction
Figure BDA0003545241200001112
13.5g (25mmol, 1.00eq.) of compound h (a), 21.3ml (128mmol, 5.2eq.) of 3-bromobiphenyl and 7.20g of potassium carbonate (52.1mmol, 2.10eq.) are mixed in 220ml of dry DMF and inertized under argon. Then, 0.62g (2.7mmol, 0.11eq) of 1, 3-bis (2-pyridyl) -1, 3-propanedione and 0.52g (2.7mmol, 0.11eq.) of copper (I) iodide were added to the mixture, which was heated at 140 ℃ for three days. When the reaction was complete, the mixture was carefully concentrated using a rotary evaporator, and the precipitated solid was aspirated off and washed with water and ethanol. The crude product was purified twice with a hot extractant (toluene/heptane 1:1) and the resulting solid was recrystallized from toluene. After sublimation, 8.2g (12mmol, 48% of theory) of the expected target compound are obtained.
The following compounds can be made analogously:
Figure BDA0003545241200001121
Figure BDA0003545241200001131
Figure BDA0003545241200001141
Figure BDA0003545241200001151
Figure BDA0003545241200001161
Figure BDA0003545241200001171
i) nucleophilic substitution:
Figure BDA0003545241200001172
20.3g (61mmol) of the lactam compound (8h) are dissolved in 300ml of dimethylformamide under an inert atmosphere and mixed with 3g of NaH in mineral oil (60%, 75 mmol). After 1 hour at room temperature, 24g (63mmol) of 2-chloro-4-phenyl-benzo [ h ]]A solution of quinazoline in 150mL of dimethylformamide was added dropwise to the mixture. The reaction mixture was stirred at room temperature for 12 hours. After this time, the reaction mixture was poured onto ice and extracted 3 times with dichloromethane. The combined organic phases are passed over Na2SO4Dried and concentrated. The residue was recrystallized from toluene.
Yield: 28.9g (49mmol), corresponding to 81% of theory.
The following compounds can be made analogously:
Figure BDA0003545241200001181
Figure BDA0003545241200001191
Figure BDA0003545241200001201
B) fabrication of OLEDs
The following examples E4 to E12 (see Table 1) describe the use of the materials of the invention in OLEDs.
Pretreatment of examples E1 to E12:
the glass plate coated with structured ITO (indium tin oxide, 50nm) was first treated with an oxygen plasma and then with an argon plasma before coating. These plasma treated glass plates form the substrate to which the OLED is applied.
In principle, the OLED has the following layer structure: substrate/optional Interlayer (IL)/Hole Injection Layer (HIL)/Hole Transport Layer (HTL)/Electron Blocking Layer (EBL)/emissive layer (EML)/optional Hole Blocking Layer (HBL)/Electron Transport Layer (ETL)/optional Electron Injection Layer (EIL) and finally a cathode. The cathode is formed from a 100nm thick layer of aluminum. The exact structure of the OLED is shown in table 1. Table 2 lists the materials used for OLED fabrication. Tables 3 and 4 list the OLED data.
All materials were applied by thermal vapor deposition in a vacuum chamber. The luminescent layer is always composed of at least one host material (host material) and a luminescent dopant (emitter) which is mixed with the host material in a certain volume proportion by co-evaporation.
Expressions such as IC1: EG1: TER1 (45%: 45%: 10%) here mean that the material IC1 is present in the layer in a proportion by volume of 45%, EG1 is present in the layer in a proportion by volume of 45%, and TER1 is present in the layer in a proportion by volume of 10%. Similarly, the electron transport layer may also be composed of a mixture of two materials.
The OLEDs are characterized in a standard way.
For this purpose, the electroluminescence spectra, the current efficiency (CE, measured in cd/A) and the external quantum efficiency (EQE, measured in%) as a function of the luminescence density, calculated from the current-voltage-luminescence density characteristic lines which exhibit Lambertian luminescence characteristics, were determined. At 1000cd/m2The electroluminescence spectrum was measured at the luminescence density of (1), and the CIE 1931x and y color coordinates were measured. In Table 3 below, U1000 corresponds to up to 1000cd/m2eEQE 1000 corresponds to 1000cd/m2External quantum efficiency.
Lifetime LT is defined as the current density j at constant0Time in hours (h) until the lower initial luminous density falls to a specific level L1 in% of the initial luminous density.
L1 ═ 95% in table 3 below means that the given lifetime LT corresponds to the time until the luminous density falls to 95% of its initial value.
The results are shown in Table 3.
Use of the inventive materials in OLEDs
The compounds EG1 to EG6 according to the invention can be used as matrix materials in the light-emitting layers of red-phosphorescent OLEDs in examples E4 to E11.
Table 4 summarizes the results of some examples. The use of the compounds of the invention as matrix material for phosphorescent OLEDs leads to better performance of the OLEDs in terms of operating voltage, external quantum efficiency and lifetime compared to OLEDs comprising the comparative compounds V1 and V2.
Table 1: structure of OLED
Figure BDA0003545241200001221
Table 2: structure of materials used in OLED
Figure BDA0003545241200001222
Figure BDA0003545241200001231
Figure BDA0003545241200001241
Table 3: OLED data
Figure BDA0003545241200001242

Claims (20)

1. A compound of the formula (1),
Figure FDA0003545241190000011
where the following applies to the symbols and labels used:
ArSon each occurrence, identically or differently, represents a single bond or an aromatic or heteroaromatic ring system having from 5 to 30 aromatic ring atoms, which may be substituted by one or more R groups;
X1to X4At each occurrence, identically or differently representing CR1Or N;
Y1to Y4At each occurrence, identically or differently representing CR2Or N; provided that Ar shown in formula (1)SRadical and one Y representing C1、Y2、Y3Or Y4Bonding of groups; and exactly two non-adjacent Y groups, i.e. Y1And Y4、Y1And Y3Or Y2And Y4Represents N;
the method is characterized in that:
Z1to Z8At each occurrence, identically or differently representing CR3Or N; wherein is selected from Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7And Z7-Z8At least two adjacent Z groups together form a heteroaromatic ring system selected from the group consisting of the formulae (Het-1) or (Het-2),
Figure FDA0003545241190000021
wherein
(symbol)*Indication and Z in formula (1)1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7Or Z7-Z8The bonding position of (a);
Z9to Z12At each occurrence, identically or differently represents CR3Or N;
RNon each occurrence, the same or different indicates: h, D, F, Cl, Br, I, CN, Si (R)3Straight-chain alkyl, alkoxy or thioalkyl groups having 1 to 40C atoms or branched or cyclic alkyl, alkoxy or thioalkyl groups having 3 to 40C atoms, which may each be substituted by one or more R groups, where in each case one or more non-adjacent CH groups2The radicals may be substituted by RC ═ CR, C ≡ C, Si (R)2、Ge(R)2、Sn(R)2、C=O、C=S、C=Se、P(=O)(R)、SO、SO2O, S or CONR and in which one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, an aromatic or heteroaromatic ring system having from 5 to 60 aromatic ring atoms, which may be substituted in each case by one or more R groups, or an aryloxy group having from 5 to 60 aromatic ring atoms, which may be substituted by one or more R groups;
and is selected from Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7、Z7-Z8、Z9-Z10、Z10-Z11And Z11-Z12Together at least two adjacent Z groups form an aromatic ring of formula (Aro-1),
Figure FDA0003545241190000022
wherein Z13To Z16At each occurrence, identically or differently representing CR3Or N; and wherein the symbols*Indication with Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z6-Z7、Z7-Z8、Z9-Z10、Z10-Z11Or Z11-Z12The bonding position of (a);
R1、R2and R3On each occurrence, the same or different indicates: h, D, F, Cl, Br, I, CHO, CN, C (═ O) Ar, P (═ O) (Ar)2,S(=O)Ar,S(=O)2Ar,N(R)2,N(Ar)2,NO2,Si(R)3,B(OR)2,OSO2R, a linear alkyl, alkoxy or thioalkyl radical having 1 to 40C atoms or a branched or cyclic alkyl, alkoxy or thioalkyl radical having 3 to 40C atoms, which may each be substituted by one or more R radicals, where in each case one or more non-adjacent CH radicals2The radicals may be substituted by RC ═ CR, C ≡ C, Si (R)2、Ge(R)2、Sn(R)2、C=O、C=S、C=Se、P(=O)(R)、SO、SO2O, S or CONR and in which one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, an aromatic or heteroaromatic ring system having from 5 to 60 aromatic ring atoms, which can be substituted in each case by one or more R groups, or an aryloxy group having from 5 to 60 aromatic ring atoms, which can be substituted by one or more R groups; wherein two adjacent R1The radicals may together form an aliphatic or aromatic ring system which may be substituted by one or more R groups, where one R group2Group and one R1The radicals may form a ring which may be substituted by one or more R groups, and wherein two adjacent R groups3The groups may together form an aliphatic or aromatic ring system, which may be substituted with one or more R groups;
r, on each occurrence, represents, identically or differently: h, D, F, Cl, Br, I, CHO, CN, C (═ O) Ar, P (═ O) (Ar)2,S(=O)Ar,S(=O)2Ar,N(R′)2,N(Ar)2,NO2,Si(R′)3,B(OR′)2,OSO2R 'is a linear alkyl, alkoxy or thioalkyl radical having 1 to 40C atoms or a branched or cyclic alkyl, alkoxy or thioalkyl radical having 3 to 40C atoms, which may each be substituted by one or more R' radicals, where in each case one or more non-adjacent CH radicals2The radicals may be substituted by R ' C ═ CR ', C ≡ C, Si (R ')2、Ge(R′)2、Sn(R′)2、C=O、C=S、C=Se、P(=O)(R′)、SO、SO2O, S or CONR' and in which one or more H atoms may be replaced by D, F, Cl, Br, I, CN or NO2Instead, an aromatic or heteroaromatic ring system having from 5 to 60 aromatic ring atoms, which can be substituted in each case by one or more R 'groups, or an aryloxy group having from 5 to 60 aromatic ring atoms, which can be substituted by one or more R' groups; wherein two adjacent R groups may together form an aliphatic or aromatic ring system, which may be substituted by one or more R' groups;
ar is, identically or differently on each occurrence, an aromatic or heteroaromatic ring system having from 5 to 60 aromatic ring atoms, which may also be substituted in each case by one or more R' groups;
r', at each occurrence, represents, identically or differently: h, D, F, Cl, Br, I, CN, a linear alkyl, alkoxy or thioalkyl radical having 1 to 20C atoms or a branched or cyclic alkyl, alkoxy or thioalkyl radical having 3 to 20C atoms, where in each case one or more non-adjacent CH' s2The radicals being selected from SO, SO2O, S and in which one or more H atoms may be replaced by D, F, Cl, Br or I, or an aromatic or heteroaromatic ring system having from 5 to 24 aromatic ring atoms.
2. The compound of claim 1, wherein:
-Y4represents N;
-Y3and Ar in formula (1)SThe radicals are bonded and represent C;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
3. Compound according to claim 1 or 2, characterized in that Y2Represents N and Y1Represents CR2
4. Compound according to one or more of the preceding claims, characterized in that X1To X4At each occurrence, identically or differently representing CR1
5. The compound according to one or more of the preceding claims, characterized in that it is selected from the compounds of formulae (2) to (13),
Figure FDA0003545241190000051
Figure FDA0003545241190000061
Figure FDA0003545241190000071
wherein
-symbol X1-X4、ArSAnd RNHas the same meaning as in claim 1;
-Z1-Z12at each occurrence, identically or differently representing CR3Or N;
-in formulae (2), (3), (6) and (7), selected from Z1-Z2、Z2-Z3、Z3-Z4、Z5-Z6、Z9-Z10、Z10-Z11And Z11-Z12At least two adjacent Z groups together form an aromatic ring of formula (Aro-1) as defined in claim 1;
-in formulae (4), (5), (8) and (9), selected from Z1-Z2、Z2-Z3、Z3-Z4、Z7-Z8、Z9-Z10、Z10-Z11And Z11-Z12At least two adjacent Z groups together form an aromatic ring of formula (Aro-1) as defined in claim 1; and wherein
-in formulae (10), (11), (12) and (13), selected from Z1-Z2、Z2-Z3、Z3-Z4、Z9-Z10、Z10-Z11And Z11-Z12At least two adjacent Z groups together form an aromatic ring of formula (Aro-1) as defined in claim 1;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
6. The compound according to one or more of the preceding claims, characterized in that it is selected from the compounds of formulae (2-1) to (2-7) or (3-1) to (3-7),
Figure FDA0003545241190000081
Figure FDA0003545241190000091
Figure FDA0003545241190000101
Figure FDA0003545241190000111
Figure FDA0003545241190000121
wherein
X1-X4、ArS、R3And RNHas the same meaning as in claim 1;
one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
p is an integer of 0 to 2;
m is an integer of 0 to 4; and is
n is an integer of 0 to 6.
7. Compound according to one or more of claims 1 to 5, characterized in that it is selected from the compounds of formulae (4-1) to (4-7) or (5-1) to (5-7),
Figure FDA0003545241190000131
Figure FDA0003545241190000141
Figure FDA0003545241190000151
Figure FDA0003545241190000161
wherein
X1-X4、ArS、R3And RNHas the following advantagesThe same meaning as in claim 1;
one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
p is an integer of 0 to 2;
m is an integer of 0 to 4; and is
n is an integer of 0 to 6.
8. The compound according to one or more of claims 1 to 5, characterized in that the compound is selected from compounds of formulae (6-1) to (6-7) or (7-1) to (7-7),
Figure FDA0003545241190000171
Figure FDA0003545241190000181
Figure FDA0003545241190000191
Figure FDA0003545241190000201
wherein
-X1-X4、ArS、R3And RNHas the same meaning as in claim 1;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
9. The compound according to one or more of claims 1 to 5, characterized in that the compound is selected from compounds of formulae (8-1) to (8-7) or (9-1) to (9-7),
Figure FDA0003545241190000211
Figure FDA0003545241190000221
Figure FDA0003545241190000231
Figure FDA0003545241190000241
wherein
-X1-X4、ArS、R3And RNHas the same meaning as in claim 1;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
10. The compound according to one or more of claims 1 to 5, characterized in that the compound is selected from compounds of formulae (10-1) to (10-6) or (11-1) to (11-6),
Figure FDA0003545241190000251
Figure FDA0003545241190000261
Figure FDA0003545241190000271
Figure FDA0003545241190000281
wherein
-X1-X4、ArS、R3And RNHas the same meaning as in claim 1;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
11. The compound according to one or more of claims 1 to 5, characterized in that it is selected from the compounds of formulae (12-1) to (12-6) or (13-1) to (13-6),
Figure FDA0003545241190000291
Figure FDA0003545241190000301
Figure FDA0003545241190000311
wherein
-X1-X4、ArS、R3And RNHas the same meaning as in claim 1;
-one Y1Or Y2The radical corresponding to N and the other Y1Or Y2Radical corresponds to CR2
-p is an integer from 0 to 2;
-m is an integer from 0 to 4; and is
-n is an integer from 0 to 6.
12. Compound according to one or more of the preceding claims, characterized in that RNOn each occurrence, the same or different indicates: phenyl, biphenyl, terphenyl, quaterphenyl, fluorene, spirobifluorene, naphthalene, anthracene, phenanthrene, terphenyl, fluoranthene, indole, benzofuran, benzothiophene, dibenzofuran, dibenzothiophene, carbazole, indenocarbazole, indolocarbazole, phenanthroline, pyridine, pyrimidine, pyrazine, pyridazine, triazine, quinolone, benzopyridine, benzopyridazine, benzopyrimidine, quinazoline, benzimidazole, or a combination of two or three of these groups, each of which may be substituted with one or more R groups.
13. A formulation comprising at least one compound according to one or more of claims 1 to 12 and at least one solvent.
14. An electronic device comprising at least one compound according to one or more of claims 1 to 12.
15. Electronic device according to claim 14, characterized in that the electronic device is selected from the group consisting of organic electroluminescent devices, organic integrated circuits, organic field effect transistors, organic thin film transistors, organic light emitting transistors, organic solar cells, dye sensitized organic solar cells, organic optical detectors, organic photoreceptors, organic field quench devices, light emitting electrochemical cells, organic laser diodes and organic plasma light emitting devices.
16. Electronic device according to claim 14 or 15, which is an organic electroluminescent device, characterized in that the compounds according to one or more of claims 1 to 12 are used as matrix material, hole-transport material or electron-transport material for light emitters.
17. Electronic device according to claim 16, characterized in that the compound according to one or more of claims 1 to 12 is used as a matrix material in a light-emitting layer comprising at least one compound according to one or more of claims 1 to 12 and at least one emitter.
18. Electronic device according to claim 17, characterized in that the light-emitting layer comprises:
-as a first matrix material a compound according to one or more of claims 1 to 12;
-a second matrix material different from the first matrix material;
and at least one light emitter.
19. Electronic device according to claim 18, characterized in that the second host material is selected from the group consisting of lactams, carbazole derivatives and indenocarbazole derivatives.
20. Electronic device according to one or more of claims 17 to 19, characterised in that the light emitter is a phosphorescent material.
CN202080064440.7A 2019-09-16 2020-09-15 Material of organic electroluminescent device Pending CN114450286A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19197591 2019-09-16
EP19197591.1 2019-09-16
PCT/EP2020/075693 WO2021052924A1 (en) 2019-09-16 2020-09-15 Materials for organic electroluminescent devices

Publications (1)

Publication Number Publication Date
CN114450286A true CN114450286A (en) 2022-05-06

Family

ID=67981972

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202080064440.7A Pending CN114450286A (en) 2019-09-16 2020-09-15 Material of organic electroluminescent device

Country Status (3)

Country Link
EP (1) EP4031546A1 (en)
CN (1) CN114450286A (en)
WO (1) WO2021052924A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024371A (en) * 2011-11-01 2014-09-03 默克专利有限公司 Organic electroluminescent device
CN105593228A (en) * 2013-07-02 2016-05-18 默克专利有限公司 Spiro-condensed lactam compounds for organic electroluminescent devices
CN109071580A (en) * 2016-04-29 2018-12-21 默克专利有限公司 Material for organic electroluminescence device
CN109096254A (en) * 2017-06-20 2018-12-28 江西师范大学 Quinazoline derivative and preparation method and application thereof

Family Cites Families (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4539507A (en) 1983-03-25 1985-09-03 Eastman Kodak Company Organic electroluminescent devices having improved power conversion efficiencies
JPH07133483A (en) 1993-11-09 1995-05-23 Shinko Electric Ind Co Ltd Organic luminescent material for el element and el element
DE60031729T2 (en) 1999-05-13 2007-09-06 The Trustees Of Princeton University LIGHT-EMITTING, ORGANIC, ELECTROPHOSPHORESCENCE-BASED ARRANGEMENT WITH VERY HIGH QUANTITY LOSSES
CN1840607B (en) 1999-12-01 2010-06-09 普林斯顿大学理事会 Complexes of form l2mx as phosphorescent dopants for organic LEDs
TW532048B (en) 2000-03-27 2003-05-11 Idemitsu Kosan Co Organic electroluminescence element
US20020121638A1 (en) 2000-06-30 2002-09-05 Vladimir Grushin Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
CN102041001B (en) 2000-08-11 2014-10-22 普林斯顿大学理事会 Organometallic compounds and emission-shifting organic electrophosphorescence
JP4154138B2 (en) 2000-09-26 2008-09-24 キヤノン株式会社 Light emitting element, display device and metal coordination compound
JP4154140B2 (en) 2000-09-26 2008-09-24 キヤノン株式会社 Metal coordination compounds
JP4154139B2 (en) 2000-09-26 2008-09-24 キヤノン株式会社 Light emitting element
ITRM20020411A1 (en) 2002-08-01 2004-02-02 Univ Roma La Sapienza SPIROBIFLUORENE DERIVATIVES, THEIR PREPARATION AND USE.
JP4411851B2 (en) 2003-03-19 2010-02-10 コニカミノルタホールディングス株式会社 Organic electroluminescence device
KR101162933B1 (en) 2003-04-15 2012-07-05 메르크 파텐트 게엠베하 Mixtures of matrix materials and organic semiconductors capable of emission, use of the same and electronic components containing said mixtures
EP1617710B1 (en) 2003-04-23 2015-05-20 Konica Minolta Holdings, Inc. Material for organic electroluminescent device, organic electroluminescent device, illuminating device and display
DE10333232A1 (en) 2003-07-21 2007-10-11 Merck Patent Gmbh Organic electroluminescent element
DE10338550A1 (en) 2003-08-19 2005-03-31 Basf Ag Transition metal complexes with carbene ligands as emitters for organic light-emitting diodes (OLEDs)
DE10345572A1 (en) 2003-09-29 2005-05-19 Covion Organic Semiconductors Gmbh metal complexes
US7795801B2 (en) 2003-09-30 2010-09-14 Konica Minolta Holdings, Inc. Organic electroluminescent element, illuminator, display and compound
EP1687859B1 (en) 2003-11-25 2013-08-07 Merck Patent GmbH Organic electroluminescent element
US7790890B2 (en) 2004-03-31 2010-09-07 Konica Minolta Holdings, Inc. Organic electroluminescence element material, organic electroluminescence element, display device and illumination device
DE102004023277A1 (en) 2004-05-11 2005-12-01 Covion Organic Semiconductors Gmbh New material mixtures for electroluminescence
US7598388B2 (en) 2004-05-18 2009-10-06 The University Of Southern California Carbene containing metal complexes as OLEDs
JP4862248B2 (en) 2004-06-04 2012-01-25 コニカミノルタホールディングス株式会社 Organic electroluminescence element, lighting device and display device
ITRM20040352A1 (en) 2004-07-15 2004-10-15 Univ Roma La Sapienza OLIGOMERIC DERIVATIVES OF SPIROBIFLUORENE, THEIR PREPARATION AND THEIR USE.
KR101289923B1 (en) 2005-05-03 2013-07-25 메르크 파텐트 게엠베하 Organic electroluminescent device and boric acid and borinic acid derivatives used therein
WO2007063754A1 (en) 2005-12-01 2007-06-07 Nippon Steel Chemical Co., Ltd. Compound for organic electroluminescent element and organic electroluminescent element
DE102006025777A1 (en) 2006-05-31 2007-12-06 Merck Patent Gmbh New materials for organic electroluminescent devices
WO2008056746A1 (en) 2006-11-09 2008-05-15 Nippon Steel Chemical Co., Ltd. Compound for organic electroluminescent device and organic electroluminescent device
WO2009030981A2 (en) 2006-12-28 2009-03-12 Universal Display Corporation Long lifetime phosphorescent organic light emitting device (oled) structures
DE102007002714A1 (en) 2007-01-18 2008-07-31 Merck Patent Gmbh New materials for organic electroluminescent devices
DE102007053771A1 (en) 2007-11-12 2009-05-14 Merck Patent Gmbh Organic electroluminescent devices
US7862908B2 (en) 2007-11-26 2011-01-04 National Tsing Hua University Conjugated compounds containing hydroindoloacridine structural elements, and their use
DE102008027005A1 (en) 2008-06-05 2009-12-10 Merck Patent Gmbh Organic electronic device containing metal complexes
DE102008033943A1 (en) 2008-07-18 2010-01-21 Merck Patent Gmbh New materials for organic electroluminescent devices
DE102008036247A1 (en) 2008-08-04 2010-02-11 Merck Patent Gmbh Electronic devices containing metal complexes
DE102008036982A1 (en) 2008-08-08 2010-02-11 Merck Patent Gmbh Organic electroluminescent device
DE102008048336A1 (en) 2008-09-22 2010-03-25 Merck Patent Gmbh Mononuclear neutral copper (I) complexes and their use for the production of optoelectronic devices
KR101506919B1 (en) 2008-10-31 2015-03-30 롬엔드하스전자재료코리아유한회사 Novel compounds for organic electronic material and organic electronic device using the same
CN102076813B (en) 2008-11-11 2016-05-18 默克专利有限公司 Organic electroluminescence device
DE102008056688A1 (en) 2008-11-11 2010-05-12 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102008057050B4 (en) 2008-11-13 2021-06-02 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102008057051B4 (en) 2008-11-13 2021-06-17 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102009007038A1 (en) 2009-02-02 2010-08-05 Merck Patent Gmbh metal complexes
DE102009011223A1 (en) 2009-03-02 2010-09-23 Merck Patent Gmbh metal complexes
DE102009013041A1 (en) 2009-03-13 2010-09-16 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102009023155A1 (en) 2009-05-29 2010-12-02 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102009031021A1 (en) 2009-06-30 2011-01-05 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102009041414A1 (en) 2009-09-16 2011-03-17 Merck Patent Gmbh metal complexes
DE102009048791A1 (en) 2009-10-08 2011-04-14 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102009057167A1 (en) 2009-12-05 2011-06-09 Merck Patent Gmbh Electronic device containing metal complexes
DE102010005697A1 (en) 2010-01-25 2011-07-28 Merck Patent GmbH, 64293 Connections for electronic devices
DE102010012738A1 (en) 2010-03-25 2011-09-29 Merck Patent Gmbh Materials for organic electroluminescent devices
DE102010019306B4 (en) 2010-05-04 2021-05-20 Merck Patent Gmbh Organic electroluminescent devices
CN102939296B (en) 2010-06-15 2016-02-10 默克专利有限公司 Metal complex
DE102010027317A1 (en) 2010-07-16 2012-01-19 Merck Patent Gmbh metal complexes
DE102010048608A1 (en) 2010-10-15 2012-04-19 Merck Patent Gmbh Materials for organic electroluminescent devices
CN104428392B (en) 2012-07-13 2017-05-31 默克专利有限公司 Metal complex
EP3424936B1 (en) 2012-08-07 2021-04-07 Merck Patent GmbH Metal complexes
JP6556628B2 (en) 2012-12-21 2019-08-07 メルク パテント ゲーエムベーハー Metal complex
US20150333280A1 (en) 2012-12-21 2015-11-19 Merck Patent Gmbh Metal Complexes
JP6556630B2 (en) 2012-12-21 2019-08-07 メルク パテント ゲーエムベーハー Metal complex
JP2018050093A (en) 2015-02-03 2018-03-29 シャープ株式会社 Radio reception device, radio transmission device, communication method, and communication system
JP6772188B2 (en) 2015-02-03 2020-10-21 メルク、パテント、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツングMerck Patent GmbH Metal complex
KR102664605B1 (en) 2015-08-25 2024-05-10 유디씨 아일랜드 리미티드 metal complex
JP7039549B2 (en) 2016-07-14 2022-03-22 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング Metal complex
WO2018041769A1 (en) 2016-08-30 2018-03-08 Merck Patent Gmbh Binuclear and trinuclear metal complexes composed of two inter-linked tripodal hexadentate ligands for use in electroluminescent devices
EP3573973B1 (en) * 2017-01-25 2023-12-06 Merck Patent GmbH Carbazole derivatives
TW201843143A (en) * 2017-03-13 2018-12-16 德商麥克專利有限公司 Compounds containing arylamine structures

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024371A (en) * 2011-11-01 2014-09-03 默克专利有限公司 Organic electroluminescent device
CN105593228A (en) * 2013-07-02 2016-05-18 默克专利有限公司 Spiro-condensed lactam compounds for organic electroluminescent devices
CN109071580A (en) * 2016-04-29 2018-12-21 默克专利有限公司 Material for organic electroluminescence device
CN109096254A (en) * 2017-06-20 2018-12-28 江西师范大学 Quinazoline derivative and preparation method and application thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SILVIA G. RULL ET AL.: "C-N Coupling of Indoles and Carbazoles with Aromatic Chlorides Catalyzed by a Single-Component NHC-Nickel(0) Precursor", ADVANCED SYNTHESIS & CATALYSIS, vol. 357, no. 5, pages 907 - 911 *

Also Published As

Publication number Publication date
WO2021052924A1 (en) 2021-03-25
EP4031546A1 (en) 2022-07-27

Similar Documents

Publication Publication Date Title
TWI680969B (en) Materials for organic electroluminescent devices
CN108699438B (en) Material for organic electroluminescent device
CN109071580B (en) Material for organic electroluminescent device
TWI633106B (en) Organic electroluminescent device
CN106488917B (en) Material for organic electroluminescent device
CN106459018B (en) Material for organic light emitting device
KR102543777B1 (en) Materials for organic electroluminescent devices
CN108350352B (en) Material for organic electroluminescent device
TW202225147A (en) Materials for organic electroluminescent devices
KR20180037050A (en) Material for organic electroluminescence device
CN114222738A (en) Material for organic electroluminescent device
CN111918950A (en) Material for electronic devices
TW201839094A (en) Materials for organic electroluminescent devices
CN110914244A (en) Spirobifluorene derivatives for use in electronic devices
CN114730843A (en) Compounds for electronic devices
CN111225919A (en) Material for organic electroluminescent device
CN111065640A (en) Material for organic electroluminescent device
CN112219292A (en) Organic electroluminescent device
CN111557122A (en) Material for organic electroluminescent device
CN115335382A (en) Material for organic electroluminescent device
CN111819180A (en) Compounds for electronic devices
KR20210091762A (en) Materials for organic electroluminescent devices
CN112384595A (en) Material for organic electroluminescent device
KR20180077216A (en) Material for organic electroluminescence device
CN111801332A (en) Compounds for electronic devices

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20220506

WD01 Invention patent application deemed withdrawn after publication